Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Vroonen

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Hypertension|March 2, 2017
High prevalence of cardiac electric abnormalities in patients with phaeochromocytomasElena Berra, Maria C Gonzalez, Christophe Scavée, et al.
Endocrine-Related Cancer|May 19, 2017
<i>KIF1B</i> and <i>NF1</i> are the most frequently mutated genes in paraganglioma and pheochromocytoma tumorsLucie Evenepoel, Raphaël Helaers, Laurent Vroonen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platformEtienne Cavalier, Daniela Betea, Marie-Louise Schleck, et al.
Neuroradiology|April 8, 2015
Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender differenceJulie Kreutz, Laurent Vroonen, Francoise Cattin, et al.
Endocrine Connections|August 21, 2025
Validation of a new non-invasive predictive score (KASAI) for primary aldosteronism subtypingGuillaume Pierman, Karin Zibar Tomsic, Darko Kastelan, et al.
Endocrine|November 18, 2016
Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine|October 7, 2016
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine Connections|March 10, 2023
PAI-BEL: a Belgian multicentre survey of primary adrenal insufficiencyNatacha Driessens, Madhu Prasai, Orsalia Alexopoulou, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|November 3, 2022
Corrigendum to "Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects" [Clin. Mass Spectrom. 9 (2018) 7-17]Caroline M Le Goff, Ana Gonzalez-Antuña, Stéphanie D Peeters, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|August 28, 2024
Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjectsCaroline M Le Goff, Ana Gonzalez-Antuña, Stéphanie D Peeters, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Hypertension|March 2, 2017
High prevalence of cardiac electric abnormalities in patients with phaeochromocytomasElena Berra, Maria C Gonzalez, Christophe Scavée, et al.
Endocrine-Related Cancer|May 19, 2017
<i>KIF1B</i> and <i>NF1</i> are the most frequently mutated genes in paraganglioma and pheochromocytoma tumorsLucie Evenepoel, Raphaël Helaers, Laurent Vroonen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platformEtienne Cavalier, Daniela Betea, Marie-Louise Schleck, et al.
Neuroradiology|April 8, 2015
Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender differenceJulie Kreutz, Laurent Vroonen, Francoise Cattin, et al.
Endocrine Connections|August 21, 2025
Validation of a new non-invasive predictive score (KASAI) for primary aldosteronism subtypingGuillaume Pierman, Karin Zibar Tomsic, Darko Kastelan, et al.
Endocrine|November 18, 2016
Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine|October 7, 2016
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine Connections|March 10, 2023
PAI-BEL: a Belgian multicentre survey of primary adrenal insufficiencyNatacha Driessens, Madhu Prasai, Orsalia Alexopoulou, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|November 3, 2022
Corrigendum to "Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects" [Clin. Mass Spectrom. 9 (2018) 7-17]Caroline M Le Goff, Ana Gonzalez-Antuña, Stéphanie D Peeters, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|August 28, 2024
Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjectsCaroline M Le Goff, Ana Gonzalez-Antuña, Stéphanie D Peeters, et al.
Pageof 3